Updates are available Correction dated 2021-02-19

Article History

Received: 13 May 2020

Accepted: 18 December 2020

First Online: 3 February 2021

Change Date: 19 February 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s41606-021-00060-8

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: RO and JC declared no conflict of interest. SK has received equipment support from Neuronetics, Inc. PC has received research grant support from Pfizer, Inc.; equipment support from Neuronetics, Inc.; and received supplies and genotyping services from Assurex Health, Inc. for investigator-initiated studies. He is the primary investigator for a multicenter study funded by Neuronetics, Inc. and a site primary investigator for a study funded by NeoSync, Inc. Dr. Croarkin is a consultant for Procter & Gamble Company and Myriad Neuroscience.